These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8525532)

  • 1. Molecular analysis of C3 allotypes related to transplant outcome in human renal allografts.
    Andrews PA; Finn JE; Mathieson PW; Sacks SH
    Transplantation; 1995 Dec; 60(11):1342-6. PubMed ID: 8525532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of C3 allotypes in patients with systemic vasculitis.
    Finn JE; Zhang L; Agrawal S; Jayne DR; Oliveira DB; Mathieson PW
    Nephrol Dial Transplant; 1994; 9(11):1564-7. PubMed ID: 7870343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3 polymorphisms and allograft outcome in renal transplantation.
    Varagunam M; Yaqoob MM; Döhler B; Opelz G
    N Engl J Med; 2009 Feb; 360(9):874-80. PubMed ID: 19246358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of donor C3 allotype on late renal-transplantation outcome.
    Brown KM; Kondeatis E; Vaughan RW; Kon SP; Farmer CK; Taylor JD; He X; Johnston A; Horsfield C; Janssen BJ; Gros P; Zhou W; Sacks SH; Sheerin NS
    N Engl J Med; 2006 May; 354(19):2014-23. PubMed ID: 16687714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: polymorphisms of CCR5.
    Cha RH; Yang SH; Kim HS; Kim SM; Park MH; Ha J; Kim YS
    Nephrol Dial Transplant; 2009 Sep; 24(9):2919-25. PubMed ID: 19561149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The difference between human C3F and C3S results from a single amino acid change from an asparagine to an aspartate residue at position 1216 on the alpha-chain of the complement component, C3.
    Poznansky MC; Clissold PM; Lachmann PJ
    J Immunol; 1989 Aug; 143(4):1254-8. PubMed ID: 2473125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of C3 allotypes in patients with nephritic factor.
    Finn JE; Mathieson PW
    Clin Exp Immunol; 1993 Mar; 91(3):410-4. PubMed ID: 8443964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of renal secreted complement C3 to the circulating pool in humans.
    Tang S; Zhou W; Sheerin NS; Vaughan RW; Sacks SH
    J Immunol; 1999 Apr; 162(7):4336-41. PubMed ID: 10201966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of complement C3 gene variants with renal transplant outcome of deceased cardiac dead donor kidneys.
    Damman J; Daha MR; Leuvenink HG; van Goor H; Hillebrands JL; Dijk MC; Hepkema BG; Snieder H; Born Jv; de Borst MH; Bakker SJ; Navis GJ; Ploeg RJ; Seelen MA
    Am J Transplant; 2012 Mar; 12(3):660-8. PubMed ID: 22176838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement component C3 allotypes and outcomes in liver transplantation.
    Dhillon N; Walsh L; Krüger B; Mehrotra A; Ward SC; Godbold J; Radwan M; Schiano T; Murphy B; Schröppel B
    Liver Transpl; 2010 Feb; 16(2):198-203. PubMed ID: 20104494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement C3 gene polymorphism in renal transplantation (an Iranian experience).
    Bazyar N; Azarpira N; Khatami SR; Galehdari H; Salahi H
    Gene; 2012 May; 498(2):254-8. PubMed ID: 22361228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of C3 allotypes in Chinese patients with immunoglobulin A nephropathy.
    Finn JE; Li PK; Lai KN; Mathieson PW
    Am J Kidney Dis; 1994 Apr; 23(4):543-6. PubMed ID: 8154490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement C3F allotype synthesized by liver recipient modifies transplantation outcome independently from donor hepatic C3.
    Valero-Hervás DM; Sánchez-Zapardiel E; Castro MJ; Gallego-Bustos F; Cambra F; Justo I; Laguna-Goya R; Jiménez-Romero C; Moreno E; López-Medrano F; San Juan R; Fernández-Ruiz M; Aguado JM; Paz-Artal E
    Clin Transplant; 2017 Jan; 31(1):. PubMed ID: 27801525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of HLA-G polymorphism and linkage disequilibrium in renal transplant patients and their donors.
    Pirri A; Contieri FC; Benvenutti R; Bicalho Mda G
    Transpl Immunol; 2009 Jan; 20(3):143-9. PubMed ID: 18926911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C3 alleles in diseases associated with C3 activation.
    Welch TR; Berry A
    Dis Markers; 1987 Jun; 5(2):81-7. PubMed ID: 3502986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-transplant risk factors for renal allograft dysfunction at one year in Indian patients.
    Prabhu R; John GT; Shankar V; Thomas PP; Abi Abraham M; Jeyaseelan L; Jacob CK
    Natl Med J India; 2001; 14(1):18-21. PubMed ID: 11242692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mannose binding lectin (+54) exon 1 gene polymorphism in Tunisian kidney transplant patients.
    Gorgi Y; Sfar I; Aouadi H; Makhlouf M; Abderrahim E; Jendoubiayed S; Bardi R; Ben Abdallah T; Ayed K
    Transplant Proc; 2009 Mar; 41(2):660-2. PubMed ID: 19328949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplant soluble CD30 level has limited effect on acute rejection, but affects graft function in living donor kidney transplantation.
    Kim MS; Kim HJ; Kim SI; Ahn HJ; Ju MK; Kim HJ; Jeon KO; Kim YS
    Transplantation; 2006 Dec; 82(12):1602-5. PubMed ID: 17198243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretransplant detection of anti-endothelial cell antibodies could predict renal allograft outcome.
    Ismail AM; Badawi RM; El-Agroudy AE; Mansour MA
    Exp Clin Transplant; 2009 Jun; 7(2):104-9. PubMed ID: 19715514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.